Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

An Interspecies Molecular and Functional Study of Organic Cation Transporters at the Blood-Brain Barrier: From Rodents to Humans.

Chaves C, Campanelli F, Chapy H, Gomez-Zepeda D, Glacial F, Smirnova M, Taghi M, Pallud J, Perrière N, Declèves X, Menet MC, Cisternino S.

Pharmaceutics. 2020 Mar 28;12(4). pii: E308. doi: 10.3390/pharmaceutics12040308.

2.

Administration of gamma-hydroxybutyrate instead of beta-hydroxybutyrate to a liver transplant recipient suffering from propionic acidemia and cardiomyopathy: A case report on a medication prescribing error.

Tuchmann-Durand C, Thevenet E, Moulin F, Lesage F, Bouchereau J, Oualha M, Khraiche D, Brassier A, Wicker C, Gobin-Limballe S, Arnoux JB, Lacaille F, Wicart C, Coat B, Schlattler J, Cisternino S, Renolleau S, Secretan PH, De Lonlay P.

JIMD Rep. 2020 Jan 3;51(1):25-29. doi: 10.1002/jmd2.12090. eCollection 2020 Jan.

3.

Astroglial Connexin 43 Deficiency Protects against LPS-Induced Neuroinflammation: A TSPO Brain µPET Study with [18F]FEPPA.

Vignal N, Boulay AC, San C, Cohen-Salmon M, Rizzo-Padoin N, Sarda-Mantel L, Declèves X, Cisternino S, Hosten B.

Cells. 2020 Feb 7;9(2). pii: E389. doi: 10.3390/cells9020389.

4.

Improvement of epidermal covering on AEC patients with severe skin erosions by PRIMA-1MET/APR-246.

Aberdam E, Roux LN, Secrétan PH, Boralevi F, Schlatter J, Morice-Picard F, Sol S, Bodemer C, Missero C, Cisternino S, Aberdam D, Hadj-Rabia S.

Cell Death Dis. 2020 Jan 16;11(1):30. doi: 10.1038/s41419-020-2223-8.

5.

Occupational risks evaluation in a centralized antineoplastic agent preparation unit.

Dubray Q, Diallo T, Loeuillet R, Andre E, Fauqueur AS, Poil S, Thromas N, Secretan PH, Cisternino S, Schlatter J.

SAGE Open Med. 2019 Jul 27;7:2050312119866970. doi: 10.1177/2050312119866970. eCollection 2019.

6.

Corrigendum to "Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal" [Drug Alcohol Depend. 170 (2017) 43-50].

Auvity S, Goutal S, Thézé B, Chaves C, Hosten B, Kuhnast B, Saba W, Boisgard R, Buvat I, Cisternino S, Tournier N.

Drug Alcohol Depend. 2019 Aug 1;201:266-268. doi: 10.1016/j.drugalcdep.2019.05.002. Epub 2019 Jun 5. No abstract available.

PMID:
31176599
7.

Stability of warfarin sodium flavoured preservative-free oral liquid formulations.

Schlatter J, Cisternino S.

Eur J Hosp Pharm. 2018 Oct;25(e2):e98-e101. doi: 10.1136/ejhpharm-2017-001281. Epub 2017 Jul 13.

8.

Cannabidiol Increases Proliferation, Migration, Tubulogenesis, and Integrity of Human Brain Endothelial Cells through TRPV2 Activation.

Luo H, Rossi E, Saubamea B, Chasseigneaux S, Cochois V, Choublier N, Smirnova M, Glacial F, Perrière N, Bourdoulous S, Smadja DM, Menet MC, Couraud PO, Cisternino S, Declèves X.

Mol Pharm. 2019 Mar 4;16(3):1312-1326. doi: 10.1021/acs.molpharmaceut.8b01252. Epub 2019 Feb 5.

PMID:
30721081
9.

A virtual centralized cytotoxic preparation unit simulation to evaluate the pharmacy staff knowledge.

Cotteret C, Marry S, Loeuillet R, Videau M, Cisternino S, Schlatter J.

J Oncol Pharm Pract. 2019 Jul;25(5):1187-1194. doi: 10.1177/1078155218821426. Epub 2019 Jan 9.

PMID:
30626271
10.

Innovative Target for Production of Technetium-99m by Biomedical Cyclotron.

Skliarova H, Cisternino S, Cicoria G, Marengo M, Palmieri V.

Molecules. 2018 Dec 21;24(1). pii: E25. doi: 10.3390/molecules24010025.

11.

LARAMED: A Laboratory for Radioisotopes of Medical Interest.

Esposito J, Bettoni D, Boschi A, Calderolla M, Cisternino S, Fiorentini G, Keppel G, Martini P, Maggiore M, Mou L, Pasquali M, Pranovi L, Pupillo G, Rossi Alvarez C, Sarchiapone L, Sciacca G, Skliarova H, Favaron P, Lombardi A, Antonini P, Duatti A.

Molecules. 2018 Dec 21;24(1). pii: E20. doi: 10.3390/molecules24010020. Review.

12.

Isolation and differential transcriptome of vascular smooth muscle cells and mid-capillary pericytes from the rat brain.

Chasseigneaux S, Moraca Y, Cochois-Guégan V, Boulay AC, Gilbert A, Le Crom S, Blugeon C, Firmo C, Cisternino S, Laplanche JL, Curis E, Declèves X, Saubaméa B.

Sci Rep. 2018 Aug 16;8(1):12272. doi: 10.1038/s41598-018-30739-5.

13.

Asymmetric hearing loss and chronic dizziness in a patient with idiopathic normal pressure hydrocephalus.

Varakliotis T, Maspes F, Rubbo VD, Cisternino S, Lauriello M, Vitti E, Eibenstein A.

Audiol Res. 2018 Jun 6;8(1):200. doi: 10.4081/audiores.2018.200. eCollection 2018 Mar 6.

14.

In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals.

Martini P, Boschi A, Cicoria G, Zagni F, Corazza A, Uccelli L, Pasquali M, Pupillo G, Marengo M, Loriggiola M, Skliarova H, Mou L, Cisternino S, Carturan S, Melendez-Alafort L, Uzunov NM, Bello M, Alvarez CR, Esposito J, Duatti A.

Appl Radiat Isot. 2018 Sep;139:325-331. doi: 10.1016/j.apradiso.2018.05.033. Epub 2018 May 30.

PMID:
29936404
15.

[18F]FEPPA a TSPO Radioligand: Optimized Radiosynthesis and Evaluation as a PET Radiotracer for Brain Inflammation in a Peripheral LPS-Injected Mouse Model.

Vignal N, Cisternino S, Rizzo-Padoin N, San C, Hontonnou F, Gelé T, Declèves X, Sarda-Mantel L, Hosten B.

Molecules. 2018 Jun 7;23(6). pii: E1375. doi: 10.3390/molecules23061375.

16.

Sodium Transporters Are Involved in Lithium Influx in Brain Endothelial Cells.

Luo H, Gauthier M, Tan X, Landry C, Poupon J, Dehouck MP, Gosselet F, Perrière N, Bellivier F, Cisternino S, Declèves X.

Mol Pharm. 2018 Jul 2;15(7):2528-2538. doi: 10.1021/acs.molpharmaceut.8b00018. Epub 2018 Jun 14.

PMID:
29874916
17.

Positron Emission Tomography Imaging Reveals an Importance of Saturable Liver Uptake Transport for the Pharmacokinetics of Metoclopramide.

Caillé F, Goutal S, Marie S, Auvity S, Cisternino S, Kuhnast B, Pottier G, Tournier N.

Contrast Media Mol Imaging. 2018 May 8;2018:7310146. doi: 10.1155/2018/7310146. eCollection 2018.

18.

High brain distribution of a new central nervous system drug candidate despite its P-glycoprotein-mediated efflux at the mouse blood-brain barrier.

Taccola C, Cartot-Cotton S, Valente D, Barneoud P, Aubert C, Boutet V, Gallen F, Lochus M, Nicolic S, Dodacki A, Smirnova M, Cisternino S, Declèves X, Bourasset F.

Eur J Pharm Sci. 2018 May 30;117:68-79. doi: 10.1016/j.ejps.2018.02.005. Epub 2018 Feb 7.

PMID:
29427702
19.

Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primates.

Goutal S, Langer O, Auvity S, Andrieux K, Coulon C, Caillé F, Gervais P, Cisternino S, Declèves X, Tournier N.

Drug Deliv Transl Res. 2018 Jun;8(3):536-542. doi: 10.1007/s13346-017-0472-6.

PMID:
29294257
20.

Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use.

Schlatter J, Nguyen D, Zamy M, Kabiche S, Fontan JE, Cisternino S.

Eur Spine J. 2019 Jan;28(1):21-30. doi: 10.1007/s00586-017-5387-x. Epub 2017 Nov 18. Review.

PMID:
29151132
21.

Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir.

Gourdon B, Chemin C, Moreau A, Arnauld T, Baumy P, Cisternino S, Péan JM, Declèves X.

Int J Pharm. 2017 Aug 30;529(1-2):357-370. doi: 10.1016/j.ijpharm.2017.07.024. Epub 2017 Jul 10.

PMID:
28705621
22.

Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain.

Chaves C, Remiao F, Cisternino S, Decleves X.

Curr Neuropharmacol. 2017 Nov 14;15(8):1156-1173. doi: 10.2174/1570159X15666170504095823. Review.

23.

Cochlear Impairment and Autoimmune Ear Disorder in a Patient with Breast Cancer.

Fioretti A, Di Rubbo V, Peri G, Vitti E, Cisternino S, Varakliotis T, Eibenstein A.

Audiol Res. 2017 Mar 13;7(1):165. doi: 10.4081/audiores.2017.165. eCollection 2017 Feb 1.

24.

Imaging Probes and Modalities for the Study of Solute Carrier O (SLCO)-Transport Function In Vivo.

Marie S, Cisternino S, Buvat I, Declèves X, Tournier N.

J Pharm Sci. 2017 Sep;106(9):2335-2344. doi: 10.1016/j.xphs.2017.04.031. Epub 2017 Apr 25. Review.

PMID:
28454744
25.

Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.

Kabiche D, Balde IB, Majoul E, Kabiche S, Bourguignon E, Fontan JE, Cisternino S, Schlatter J.

Int J Pharm Compd. 2017 Mar-Apr;21(2):160-163.

PMID:
28346212
26.

Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal.

Auvity S, Goutal S, Thézé B, Chaves C, Hosten B, Kuhnast B, Saba W, Boisgard R, Buvat I, Cisternino S, Tournier N.

Drug Alcohol Depend. 2017 Jan 1;170:43-50. doi: 10.1016/j.drugalcdep.2016.10.037. Epub 2016 Nov 8. Erratum in: Drug Alcohol Depend. 2019 Aug 1;201:266-268.

PMID:
27875800
27.

Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method.

Beck W, Kabiche S, Balde IB, Carret S, Fontan JE, Cisternino S, Schlatter J.

J Clin Anesth. 2016 Dec;35:551-559. doi: 10.1016/j.jclinane.2016.09.025. Epub 2016 Oct 23.

PMID:
27871592
28.

Acute Morphine Exposure Increases the Brain Distribution of [18F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates.

Auvity S, Saba W, Goutal S, Leroy C, Buvat I, Cayla J, Caillé F, Bottlaender M, Cisternino S, Tournier N.

Int J Neuropsychopharmacol. 2017 Jan 1;20(1):67-71. doi: 10.1093/ijnp/pyw077.

29.

Assessment of P-Glycoprotein Transport Activity at the Human Blood-Retina Barrier with (R)-11C-Verapamil PET.

Bauer M, Karch R, Tournier N, Cisternino S, Wadsak W, Hacker M, Marhofer P, Zeitlinger M, Langer O.

J Nucl Med. 2017 Apr;58(4):678-681. doi: 10.2967/jnumed.116.182147. Epub 2016 Oct 13.

30.

Optimization and in Vivo Validation of Peptide Vectors Targeting the LDL Receptor.

Jacquot G, Lécorché P, Malcor JD, Laurencin M, Smirnova M, Varini K, Malicet C, Gassiot F, Abouzid K, Faucon A, David M, Gaudin N, Masse M, Ferracci G, Dive V, Cisternino S, Khrestchatisky M.

Mol Pharm. 2016 Dec 5;13(12):4094-4105. Epub 2016 Oct 11.

PMID:
27656777
31.

Stability-Indicating High-Performance Liquid Chromatography Assay for the Determination of Sulthiame in Pharmaceutical Dosage Forms.

Haidar A, Kabiche S, Majoul E, Balde IB, Fontan JE, Cisternino S, Schlatter J.

Anal Chem Insights. 2016 Sep 6;11:59-64. doi: 10.4137/ACI.S38656. eCollection 2016.

32.

Stability study of oral pediatric idebenone suspensions.

Schlatter J, Bourguignon E, Majoul E, Kabiche S, Balde IB, Cisternino S, Fontan JE.

Pharm Dev Technol. 2017 Mar;22(2):296-299. doi: 10.1080/10837450.2016.1231811. Epub 2016 Sep 21.

PMID:
27583702
33.

Diphenhydramine as a selective probe to study H+-antiporter function at the blood-brain barrier: Application to [11C]diphenhydramine positron emission tomography imaging.

Auvity S, Chapy H, Goutal S, Caillé F, Hosten B, Smirnova M, Declèves X, Tournier N, Cisternino S.

J Cereb Blood Flow Metab. 2017 Jun;37(6):2185-2195. doi: 10.1177/0271678X16662042. Epub 2016 Jan 1.

34.

Validation of a simple HPLC-UV method for rifampicin determination in plasma: Application to the study of rifampicin arteriovenous concentration gradient.

Goutal S, Auvity S, Legrand T, Hauquier F, Cisternino S, Chapy H, Saba W, Tournier N.

J Pharm Biomed Anal. 2016 May 10;123:173-8. doi: 10.1016/j.jpba.2016.02.013. Epub 2016 Feb 15.

PMID:
26907700
35.

Stability of Pentobarbital in Water and Oral Pediatric Suspensions.

Schlatter J, Kabiche S, Balde IB, Majoul E, Cisternino S, Fontan JE.

Ann Pharmacother. 2016 Mar;50(3):245-6. doi: 10.1177/1060028015625655. Epub 2016 Jan 4. No abstract available.

PMID:
26728367
36.

Immunoregulation at the gliovascular unit in the healthy brain: A focus on Connexin 43.

Boulay AC, Cisternino S, Cohen-Salmon M.

Brain Behav Immun. 2016 Aug;56:1-9. doi: 10.1016/j.bbi.2015.11.017. Epub 2015 Dec 7. Review.

PMID:
26674996
37.

Stability-Indicating HPLC Assay for Determination of Idebenone in Pharmaceutical Forms.

Kombath S, Balde IB, Carret S, Kabiche S, Cisternino S, Fontan JE, Schlatter J.

J Anal Methods Chem. 2015;2015:835986. doi: 10.1155/2015/835986. Epub 2015 Oct 29.

38.

Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood-Brain Barrier.

Chaves C, Gómez-Zepeda D, Auvity S, Menet MC, Crété D, Labat L, Remião F, Cisternino S, Declèves X.

J Pharm Sci. 2016 Jan;105(1):350-8. Epub 2016 Jan 13.

PMID:
26554626
39.

Stability-Indicating Assay for the Determination of Pentobarbital Sodium in Liquid Formulations.

Ajemni M, Balde IB, Kabiche S, Carret S, Fontan JE, Cisternino S, Schlatter J.

Int J Anal Chem. 2015;2015:697937. doi: 10.1155/2015/697937. Epub 2015 Oct 12.

40.

Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier.

Chapy H, Saubaméa B, Tournier N, Bourasset F, Behar-Cohen F, Declèves X, Scherrmann JM, Cisternino S.

Br J Pharmacol. 2016 Feb;173(3):497-510. doi: 10.1111/bph.13376. Epub 2016 Jan 15.

41.

Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line.

Chapy H, Goracci L, Vayer P, Parmentier Y, Carrupt PA, Declèves X, Scherrmann JM, Cisternino S, Cruciani G.

Br J Pharmacol. 2015 Oct;172(20):4888-904. doi: 10.1111/bph.13258. Epub 2015 Oct 13.

42.

A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier.

Chapy H, André P, Declèves X, Scherrmann JM, Cisternino S.

Br J Pharmacol. 2015 Oct;172(19):4714-25. doi: 10.1111/bph.13246. Epub 2015 Aug 10.

43.

Stability of Hydrocortisone Preservative-Free Oral Solutions.

Chappe J, Osman N, Cisternino S, Fontan JE, Schlatter J.

J Pediatr Pharmacol Ther. 2015 May-Jun;20(3):197-202. doi: 10.5863/1551-6776-20.3.197.

44.

Immune quiescence of the brain is set by astroglial connexin 43.

Boulay AC, Mazeraud A, Cisternino S, Saubaméa B, Mailly P, Jourdren L, Blugeon C, Mignon V, Smirnova M, Cavallo A, Ezan P, Avé P, Dingli F, Loew D, Vieira P, Chrétien F, Cohen-Salmon M.

J Neurosci. 2015 Mar 11;35(10):4427-39. doi: 10.1523/JNEUROSCI.2575-14.2015.

45.

Influence of P-Glycoprotein Inhibition or Deficiency at the Blood-Brain Barrier on (18)F-2-Fluoro-2-Deoxy-D-glucose ( (18)F-FDG) Brain Kinetics.

Tournier N, Saba W, Goutal S, Gervais P, Valette H, Scherrmann JM, Bottlaender M, Cisternino S.

AAPS J. 2015 May;17(3):652-9. doi: 10.1208/s12248-015-9739-3. Epub 2015 Feb 26.

46.

The Sarcoglycan complex is expressed in the cerebrovascular system and is specifically regulated by astroglial Cx30 channels.

Boulay AC, Saubaméa B, Cisternino S, Mignon V, Mazeraud A, Jourdren L, Blugeon C, Cohen-Salmon M.

Front Cell Neurosci. 2015 Feb 2;9:9. doi: 10.3389/fncel.2015.00009. eCollection 2015.

47.

Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability.

Chapy H, Smirnova M, André P, Schlatter J, Chiadmi F, Couraud PO, Scherrmann JM, Declèves X, Cisternino S.

Int J Neuropsychopharmacol. 2014 Oct 31;18(1). pii: pyu001. doi: 10.1093/ijnp/pyu001. Erratum in: Int J Neuropsychopharmacol. 2016 Apr 27;:.

48.

Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties.

Seleman M, Chapy H, Cisternino S, Courtin C, Smirnova M, Schlatter J, Chiadmi F, Scherrmann JM, Noble F, Marie-Claire C.

Psychopharmacology (Berl). 2014 Aug;231(16):3139-49. doi: 10.1007/s00213-014-3490-9. Epub 2014 Apr 5.

PMID:
24705903
49.

Stability of betaxolol suspensions in oral syringes and glass bottles.

Auvity S, Chiadmi FM, Cisternino S, Fontan JE, Schlatter J.

Ann Pharmacother. 2013 Sep;47(9):1237-8. doi: 10.1177/1060028013503137. No abstract available.

PMID:
24259746
50.

[¹¹C]befloxatone brain kinetics is not influenced by Bcrp function at the blood-brain barrier: a PET study using Bcrp TGEM knockout rats.

Hosten B, Boisgard R, Jacob A, Goutal S, Saubaméa B, Dollé F, Scherrmann JM, Cisternino S, Tournier N.

Eur J Pharm Sci. 2013 Nov 20;50(3-4):520-5. doi: 10.1016/j.ejps.2013.08.015. Epub 2013 Aug 24.

PMID:
23981334

Supplemental Content

Loading ...
Support Center